@article{7313f241549e49b89953148de5347304,
title = "Phase II activity of belinostat (PXD-101), carboplatin, and paclitaxel in women with previously treated ovarian cancer",
abstract = "Preclinical data show that belinostat (Bel) is synergistic with carboplatin and paclitaxel in ovarian cancer. To further evaluate the clinical activity of belinostat, carboplatin, and paclitaxel (BelCaP), a phase 1b/2 study was performed, with an exploratory phase 2 expansion planned specifically for women with recurrent epithelial ovarian cancer (EOC).",
keywords = "Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Phytogenic, Antineoplastic Combined Chemotherapy Protocols, Carboplatin, Carcinoma, Female, Humans, Hydroxamic Acids, Middle Aged, Neoplasm Recurrence, Local, Ovarian Neoplasms, Paclitaxel, Sulfonamides",
author = "Dizon, {Don S} and Lars Damstrup and Finkler, {Neil J} and Ulrik Lassen and Paul Celano and Ros Glasspool and Elizabeth Crowley and Lichenstein, {Henri S} and Poul Knoblach and Penson, {Richard T}",
year = "2012",
doi = "10.1097/IGC.0b013e31825736fd",
language = "English",
volume = "22",
pages = "979--86",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams & Wilkins",
number = "6",
}